Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
CAR T-cell therapy in the older person: indications and risks
G Shouse, AV Danilov, A Artz - Current oncology reports, 2022 - Springer
Abstract Purpose of Review Validated metrics to optimize older adult patient selection for
Chimeric Antigen Receptor T-cell therapy (CART) are lacking; however, some preliminary …
Chimeric Antigen Receptor T-cell therapy (CART) are lacking; however, some preliminary …
Past, present and future of prognostic scores in follicular lymphoma
P Mozas, A Rivero, A López-Guillermo - Blood Reviews, 2021 - Elsevier
Although most follicular lymphoma (FL) patients have prolonged survival, the identification of
those at risk of early progression, multiple relapses or histological transformation is essential …
those at risk of early progression, multiple relapses or histological transformation is essential …
Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information
R Nakajima, AJ Moskowitz, L Michaud… - Blood …, 2020 - ashpublications.org
In follicular lymphoma (FL), detection of bone marrow (BM) involvement (BMI) by 18F-
fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) …
fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) …
The simplified follicular lymphoma PRIMA‐prognostic index is useful in patients with first‐line chemo‐free rituximab‐based therapy
E Kimby, S Lockmer, H Holte… - British Journal of …, 2020 - Wiley Online Library
Follicular lymphoma (FL) is a heterogeneous disease; therefore, reliable prognostic tools
are needed to plan treatment strategies. The FL International Prognostic Index (FLIPI) was …
are needed to plan treatment strategies. The FL International Prognostic Index (FLIPI) was …
Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy
JJ Rodríguez-Sevilla, C Fernández-Rodríguez… - Blood …, 2023 - ashpublications.org
Several clinical risk models have been proposed to predict the outcome of follicular
lymphoma (FL). The development of next-generation sequencing technologies has allowed …
lymphoma (FL). The development of next-generation sequencing technologies has allowed …
[HTML][HTML] The use of the random number generator and artificial intelligence analysis for dimensionality reduction of follicular lymphoma transcriptomic data
J Carreras, YY Kikuti, M Miyaoka, S Hiraiwa… - …, 2022 - mdpi.com
Follicular lymphoma (FL) is one of the most frequent subtypes of non-Hodgkin lymphomas.
This research predicted the prognosis of 184 untreated follicular lymphoma patients (LLMPP …
This research predicted the prognosis of 184 untreated follicular lymphoma patients (LLMPP …
Comparing R-bendamustine vs. R-CHOP plus maintenance therapy as first-line systemic treatment in follicular lymphoma: a multicenter retrospective GELTAMO study
M Bastos-Oreiro, A Gutierrez, A Cabero, J López… - Cancers, 2024 - mdpi.com
Simple Summary The initial treatment for patients with advanced-stage follicular lymphoma
is usually a combo of immunochemotherapy called R-CHOP (rituximab, cyclophosphamide …
is usually a combo of immunochemotherapy called R-CHOP (rituximab, cyclophosphamide …
The pathobiology of follicular lymphoma
J Carreras - Journal of clinical and experimental hematopathology, 2023 - jstage.jst.go.jp
Follicular lymphoma is one of the most frequent lymphomas. Histologically, it is
characterized by a follicular (nodular) growth pattern of centrocytes and centroblasts; mixed …
characterized by a follicular (nodular) growth pattern of centrocytes and centroblasts; mixed …
Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies
N Gebauer, B Mengler, S Kopelke… - Journal of Cancer …, 2022 - Springer
Background The composition of the tumor microenvironment (TME) is conditioned by
immunity and the inflammatory response. Nutritional and inflammation-based risk scores …
immunity and the inflammatory response. Nutritional and inflammation-based risk scores …
The prognostic index PRIMA-PI combined with Ki67 as a better predictor of progression of disease within 24 months in follicular lymphoma
J Hu, F Gao, J Zhao, W Song, Y Wang, Y Zheng… - Frontiers in …, 2023 - frontiersin.org
Background Progression of disease within 24 months (POD24) is a risk factor for poor
survival in follicular lymphoma (FL), and there is currently no optimal prognostic model to …
survival in follicular lymphoma (FL), and there is currently no optimal prognostic model to …